Patricia Andrews
Patrimonio netto: 81 253 $ in data 31/05/2026
Patrimonio netto: 81 253 $ in data 31/05/2026
Ms. Patricia S.
Andrews is an Independent Non-Executive Director at Glenmark Pharmaceuticals Ltd. She is on the Board of Directors at Geron Corp., Glenmark Pharmaceuticals Ltd., Ichnos Glenmark Innovation, Inc. and Oncolytics Biotech, Inc. Ms. Andrews was previously employed as an Independent Director by GlycoMimetics, Inc., a Global Head-Oncology by Sumitomo Pharma Co., Ltd., a Chief Executive Officer by Sumitomo Pharma Oncology, Inc., a Chief Executive Officer & Director by Boston Biomedical, Inc., a Chief Commercial Officer & Executive VP by Incyte Corp., a Vice President-Specialty Markets & General Manager by Pfizer Inc., and a Vice President-Capital Finance by HSBC Bank USA, NA. She received her undergraduate degree from Brown University and an MBA from the University of Michigan.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2026 | 78.128 ( 0,07% ) | 81 253 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Direttore/Membro del Consiglio | 05/01/2024 |
| GLENMARK PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 14/08/2025 |
| GERON CORPORATION | Direttore/Membro del Consiglio | 25/03/2026 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Direttore/Membro del Consiglio | 01/08/2025 |
| Società | Posizione | Fine |
|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Corporate Officer/Principal | 01/01/2023 |
SUMITOMO PHARMA ONCOLOGY, INC.
SUMITOMO PHARMA ONCOLOGY, INC. BiotechnologyHealth Technology Provides biopharmaceutical research drug development services | Amministratore Delegato | 01/01/2023 |
| INCYTE CORPORATION | Corporate Officer/Principal | 29/08/2012 |
| PFIZER INC. | Corporate Officer/Principal | 01/10/2008 |
HSBC Bank USA, NA
HSBC Bank USA, NA Investment ManagersFinance HSBC Bank USA manages separate account and specializes in the use of asset allocation strategies. The firm's portfolio managers and analysts are generalists, although they do have significant investments in the stocks of small-cap European companies in the electronic technology sector. | Corporate Officer/Principal | 01/01/1990 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
HSBC Bank USA, NA
HSBC Bank USA, NA Investment ManagersFinance HSBC Bank USA manages separate account and specializes in the use of asset allocation strategies. The firm's portfolio managers and analysts are generalists, although they do have significant investments in the stocks of small-cap European companies in the electronic technology sector. | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
SUMITOMO PHARMA ONCOLOGY, INC.
SUMITOMO PHARMA ONCOLOGY, INC. BiotechnologyHealth Technology Provides biopharmaceutical research drug development services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale